PPARγ agonist-22
PPARγ agonist-22 is a PPARγ agonist. PPARγ agonist-22 promotes cellular glucose uptake. PPARγ agonist-22 reduces lipid accumulation in adipocytes. PPARγ agonist-22 can be used in the research of type 2 diabetes.
For research use only. We do not sell to patients.
- CAS No.: 931956-54-6
- Formula: C27H23N5OS
- Molecular Weight:465.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
PPAR-γ |
PPARγ agonist-22 (Compound Sn8) (12.5-200 μg/mL; 24 h) shows no cytotoxicity to 3T3-L1 preadipocytes and C2C12 myoblasts at low concentrations, but induces concentration-dependent cytotoxicity at high concentrations[1].
PPARγ agonist-22 (25 μg/mL; 8 days) exhibits anti-adipogenic activity in 3T3-L1 preadipocytes, reducing lipid accumulation to 61.03% of the control level after 8 days of differentiation[1].
PPARγ agonist-22 (100 μg/mL; 24 h) significantly increases glucose uptake in C2C12 myoblasts[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 931956-54-6
-
Molecular Weight 465.57
-
Formula C27H23N5OS
-
SMILES
O=C(C1=CC=C(C=C1)CN2C(SCC3=CC=CC=C3)=NC4=C2C=NC=C4)NCC5=NC=CC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Nath V, et al. Identification of antidiabetic leads using in-silico screening, molecular dynamics simulation, and biological evaluation using cell viability, anti-adipogenesis, glucose uptake, and peroxisome proliferator activated receptor-γ in-vitro assay. J Comput Aided Mol Des. 2026;40(1):48. Published 2026 Jan 13. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)